Levosulpiride

Levosulpiride
Names
IUPAC name
N-[[(2S)-(−)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
Identifiers
23672-07-3 YesY
ChEBI CHEBI:4119 N
ChEMBL ChEMBL267044 N
ChemSpider 599749 N
958
Jmol interactive 3D Image
KEGG D07312 YesY
PubChem 688272
UNII JTG7R315LK YesY
Properties
C15H23N3O4S
Molar mass 341.43 g·mol−1
Pharmacology
ATC code N05AL07
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Levosulpiride is a substituted benzamide antipsychotic, reported to be a selective antagonist of dopamine D2 receptor activity on both central and peripheral levels. It is an atypical neuroleptic and a prokinetic agent. Levosulpiride is also claimed to have mood elevating properties. Levosulpiride is used in the treatment of psychoses, particularly negative symptoms of schizophrenia, anxiety disorders, dysthymia, vertigo, dyspepsia, irritable bowel syndrome and premature ejaculation.

Chemically, it is the (S)-(−)-enantiomer of sulpiride.

Side effect

Side effects include amenorrhea, gynecomastia, galactorrhea, changes in libido, and neuroleptic malignant syndrome.[1]

Mechanism of action

In contrast to most other neuroleptics which block both dopamine D1 and D2 receptors, sulpiride is more selective and acts primarily as a dopamine D2 antagonist. Sulpiride appears to lack effects on norepinephrine, acetylcholine, serotonin, histamine, or gamma-aminobutyric acid (GABA) receptors. [2]

Pharmacodynamics

Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist with antipsychotic and antidepressant activity. Other benzamide derivatives include metoclopramide, tiapride, and sultopride.[3]

References

This article is issued from Wikipedia - version of the Saturday, December 12, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.